The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations

被引：36
|
作者：
Tiacci, E. [1 ]
Spanhol-Rosseto, A. [1 ]
Martelli, M. P. [1 ]
Pasqualucci, L. [2 ,3 ]
Quentmeier, H. [4 ]
Grossmann, V. [5 ]
Drexler, H. G. [4 ]
Falini, B. [1 ]
机构：
[1] Univ Perugia, Inst Hematol, Dept Clin & Expt Med, I-06100 Perugia, Italy
[2] Columbia Univ, Inst Canc Genet, New York, NY USA
[3] Columbia Univ, Dept Pathol, New York, NY USA
[4] German Collect Microorganisms & Cell Cultures, DSMZ, Braunschweig, Germany
[5] MLL, Munich, Germany
来源：
LEUKEMIA | 2012年 / 26卷 / 03期
关键词：
ACUTE MYELOID-LEUKEMIA; NUCLEOPHOSMIN;
D O I：
10.1038/leu.2011.238
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：554 / 557
页数：5
相关论文
共 50 条
  • [1] Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model
    Hollink, I. H. I. M.
    Feng, Q.
    Danen-van Oorschot, A. A.
    Arentsen-Peters, S. T. C. J. M.
    Verboon, L. J.
    Zhang, P.
    de Haas, V.
    Reinhardt, D.
    Creutzig, U.
    Trka, J.
    Pieters, R.
    van den Heuvel-Eibrink, M. M.
    Wang, J.
    Zwaan, C. M.
    LEUKEMIA, 2012, 26 (02) : 371 - 373
  • [2] NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse
    Hoellein, Alexander
    Meggendorfer, Manja
    Dicker, Frank
    Jeromin, Sabine
    Nadarajah, Niroshan
    Kern, Wolfgang
    Haferlach, Claudia
    Haferlach, Torsten
    BLOOD ADVANCES, 2018, 2 (22) : 3118 - 3125
  • [3] Impact of secondary-type mutations in NPM1 mutated AML
    Zhou, Qianghua
    Zhao, Davidson
    Zarif, Mojgan
    Yeung, Yu Wing Tony
    Richard-Carpentier, Guillaume
    Chang, Hong
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (01) : 165 - 168
  • [4] Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML
    Diaz de la Guardia, Rafael
    Gonzalez-Silva, Laura
    Lopez-Millan, Belen
    Rodriguez-Sevilla, Juan Jose
    Baroni, Matteo L.
    Bueno, Clara
    Anguita, Eduardo
    Vives, Susana
    Palomo, Laura
    Lapillonne, Helene
    Varela, Ignacio
    Menendez, Pablo
    GENES, 2020, 11 (01)
  • [5] Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients
    Wu, Quan
    Zhang, Yujiao
    Yuan, Baoyi
    Huang, Yun
    Jiang, Ling
    Liu, Fang
    Yan, Ping
    Cheng, Jiaying
    Long, Zhiquan
    Jiang, Xuejie
    CANCER MEDICINE, 2024, 13 (15):
  • [6] Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML
    Zhou, Yi
    Othus, Megan
    Walter, Roland B.
    Estey, Elihu H.
    Wu, David
    Wood, Brent L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) : 1615 - 1620
  • [7] NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1
    Zhao, Davidson
    Zarif, Mojgan
    Eladl, Entsar
    Capo-Chichi, Jose-Mario
    Smith, Adam C.
    Atenafu, Eshetu G.
    Tierens, Anne
    Minden, Mark D.
    Schuh, Andre
    Chang, Hong
    LEUKEMIA RESEARCH, 2022, 118
  • [8] Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML
    Garg, Swati
    Reyes-Palomares, Armando
    He, Lixiazi
    Bergeron, Anne
    Lavallee, Vincent-Philippe
    Lemieux, Sebastien
    Gendron, Patrick
    Rohde, Christian
    Xia, Jianglong
    Jagdhane, Prarabdha
    Mueller-Tidow, Carsten
    Lipka, Daniel B.
    Imren, Suzan
    Humphries, R. Keith
    Waskow, Claudia
    Vick, Binje
    Jeremias, Irmela
    Richard-Carpentier, Guillaume
    Hebert, Josee
    Sauvageau, Guy
    Zaugg, Judith B.
    Barabe, Frederic
    Pabst, Caroline
    BLOOD, 2019, 134 (03) : 263 - 276
  • [9] The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype
    Schneider, Friederike
    Hoster, Eva
    Unterhalt, Michael
    Schneider, Stephanie
    Dufour, Annika
    Benthaus, Tobias
    Mellert, Gudrun
    Zellmeier, Evelyn
    Kakadia, Purvi M.
    Bohlander, Stefan K.
    Feuring-Buske, Michaela
    Buske, Christian
    Braess, Jan
    Heinecke, Achim
    Sauerland, Maria C.
    Berdel, Wolfgang E.
    Buechner, Thomas
    Woermann, Bernhard J.
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    BLOOD, 2012, 119 (19) : 4383 - 4386
  • [10] The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
    Heiblig, Mael
    Duployez, Nicolas
    Marceau, Alice
    Lebon, Delphine
    Goursaud, Laure
    Plantier, Isabelle
    Stalnikiewich, Laure
    Cambier, Nathalie
    Balsat, Marie
    Fossard, Gaelle
    Labussiere-Wallet, Helene
    Barraco, Fiorenza
    Ducastelle-Lepretre, Sophie
    Sujobert, Pierre
    Huet, Sarah
    Hayette, Sandrine
    Ghesquieres, Herve
    Thomas, Xavier
    Preudhomme, Claude
    CANCERS, 2021, 13 (09)
12345